The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis
CR Holroyd, R Seth, M Bukhari, A Malaviya… - …, 2019 - academic.oup.com
Christopher R. Holroyd1, Rakhi Seth1, Marwan Bukhari2, Anshuman Malaviya3, Claire
Holmes1, Elizabeth Curtis4, Christopher Chan1, Mohammed A. Yusuf3, Anna Litwic4, 5 …
Holmes1, Elizabeth Curtis4, Christopher Chan1, Mohammed A. Yusuf3, Anna Litwic4, 5 …
Comorbidities in rheumatoid arthritis
Rheumatoid arthritis (RA) is often characterized by the burden of swollen joints, pain, and
decreased physical function, but less understood are the many manifestations of additional …
decreased physical function, but less understood are the many manifestations of additional …
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium
Some autoimmune disorders are increasingly recognized as risk factors for non-Hodgkin
lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes …
lymphoma (NHL) overall, but large-scale systematic assessments of risk of NHL subtypes …
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
AL Smitten, TA Simon, MC Hochberg… - Arthritis research & …, 2008 - Springer
Introduction The risk of malignancies in patients with rheumatoid arthritis (RA) has raised
some concern, particularly with immunosuppressive approaches to disease management …
some concern, particularly with immunosuppressive approaches to disease management …
The effect of methotrexate and anti–tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person‐years of …
Objective To ascertain the relationship between anti–tumor necrosis factor (anti‐TNF)
therapy, methotrexate (MTX), and the risk of lymphoma in patients with rheumatoid arthritis …
therapy, methotrexate (MTX), and the risk of lymphoma in patients with rheumatoid arthritis …
Comorbidities in patients with psoriasis
AB Gottlieb, F Dann - The American journal of medicine, 2009 - Elsevier
Psoriasis is a common chronic inflammatory disease that is associated with serious
comorbidities, including psoriatic arthritis, reduced quality of life, depression, malignancy …
comorbidities, including psoriatic arthritis, reduced quality of life, depression, malignancy …
BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies
T Ding, J Ledingham, R Luqmani, S Westlake… - …, 2010 - academic.oup.com
Tina Ding1, Jo Ledingham2, Raashid Luqmani3, Sarah Westlake4, Kimme Hyrich5, Mark
Lunt5, Patrick Kiely6, Marwan Bukhari7, Rikki Abernethy8, Ailsa Bosworth9, Andrew …
Lunt5, Patrick Kiely6, Marwan Bukhari7, Rikki Abernethy8, Ailsa Bosworth9, Andrew …
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
J Askling, E Baecklund, F Granath, P Geborek… - Annals of the …, 2009 - ard.bmj.com
Background: Tumour necrosis factor (TNF) antagonists have proved effective as treatment
against rheumatoid arthritis (RA), but the unresolved issue of whether the use of anti-TNF …
against rheumatoid arthritis (RA), but the unresolved issue of whether the use of anti-TNF …
Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics
KE Smedby, E Baecklund, J Askling - Cancer Epidemiology Biomarkers & …, 2006 - AACR
Certain autoimmune and chronic inflammatory conditions, such as Sjögren's syndrome
and rheumatoid arthritis (RA), have consistently been associated with an increased risk of …
and rheumatoid arthritis (RA), have consistently been associated with an increased risk of …